Diagnostic Power of Circulatory Metabolic Biomarkers as Metabolic Syndrome Risk Predictors in Community-Dwelling Older Adults in Northwest of England (A Feasibility Study)
Razieh Hassannejad, Hamsa Sharrouf, Fahimeh Haghighatdoost, Ben Kirk, Farzad Amirabdollahian
NUTRIENTS | MDPI | Published : 2021
BACKGROUND: Metabolic Syndrome (MetS) is a cluster of risk factors for diabetes and cardiovascular diseases with pathophysiology strongly linked to aging. A range of circulatory metabolic biomarkers such as inflammatory adipokines have been associated with MetS; however, the diagnostic power of these markers as MetS risk correlates in elderly has yet to be elucidated. This cross-sectional study investigated the diagnostic power of circulatory metabolic biomarkers as MetS risk correlates in older adults. METHODS: Hundred community dwelling older adults (mean age: 68.7 years) were recruited in a study, where their blood pressure, body composition and Pulse Wave Velocity (PWV) were measured; an..View full abstract
This research received no external funding. The APC was funded by MDPI Nutrients 2021 Travel Award.